Risk Evaluation and Mitigation Strategies - 0 views
-
kyra smith on 23 Jan 17Risk Evaluation and Mitigation Strategies (REMS for US FDA) and Risk Management Plan (RMP for EU) are two main risk management strategies required for medicinal and biological products to ensure that the benefits of a drug or biological product outweigh its risks without creating an undue burden on the healthcare system.